For example, the WHO calls the “UK variant” (B.1.1.7) “Alpha” and the “South Africa variant” (B.1.351) “beta”.
The P.1variant first detected in Brazil and defined a variant of concern in January. It has been identified as “gamma”. The B.1.617.2 variant was first found in India and recently reclassified from the option of interest to the variable of concern, “delta”. Interesting from “Epsilon” to “Kappa”
All viruses, including SARS-CoV-2, the coronavirus that causes COVID-19. can mutate or change at any time This is what leads to variations.
The WHO said in its announcement Monday that the new label does not replace the existing scientific name for the coronavirus strain. “It will be used for further research,” Van Kerkhov tweeted.
Although these names have their advantages. But these scientific names can be difficult to say and remember. and prone to misreporting. For this reason, people tend to resort to different names based on the location they are detected. This is a stigma and discrimination according to the WHO announcement.
It may also be incorrect. This is because there is evidence that at least some of the marked mutations have occurred independently in many places.
“To avoid this and make public communication easier. The World Health Organization is encouraging national agencies, media and others to adopt these new labels,” the WHO said.
There are some concerns that the WHO’s new Greek letter nomenclature is a bit late, and now it can complicate variable descriptions. This is because there are three possible names: scientific name. variable location-based reference Identified first and now WHO Greek Alphabet Labeling
Adalja said: “There is a problem with stigma when describing variables and labeling them by country. We know there is some backlash in India. It’s about Indian variables and people talking about that,” Adalja said. “So I understand why it happened. I think it’s just a lot of people going to think about it.”